459
Views
121
CrossRef citations to date
0
Altmetric
Review

Pathogenesis of indirect (secondary) acute lung injury

, , , &
Pages 115-126 | Published online: 09 Jan 2014

References

  • Bernard GR, Artigas A, Brigham KL et al. The American–European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med.149, 818–824 (1994).
  • Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet369, 1553–1564 (2007).
  • Peek GJ, Clemens F, Elbourne D et al. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv. Res.6, 163 (2006).
  • Rubenfeld GD, Caldwell E, Peabody E et al. Incidence and outcomes of acute lung injury. N. Engl. J. Med.353, 1685–1693 (2005).
  • Herridge MS, Angus DC. Acute lung injury – affecting many lives. N. Engl. J. Med.353, 1736–1738 (2005).
  • Brun-Buisson C, Minelli C, Bertolini G et al. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med.30, 51–61 (2004).
  • Goss CH, Brower RG, Hudson LD et al. Incidence of acute lung injury in the United States. Crit. Care Med.31, 1607–1611 (2003).
  • Yilmaz M, Iscimen R, Keegan MT et al. Six-month survival of patients with acute lung injury: prospective cohort study. Crit. Care Med.35, 2303–2307 (2007).
  • Calfee CS, Eisner MD, Ware LB et al. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit. Care Med.35, 2243–2250 (2007).
  • Vincent JL, Zambon M. Why do patients who have acute lung injury/acute respiratory distress syndrome die from multiple organ dysfunction syndrome? Implications for management. Clin. Chest Med.27, 725–731 (2006).
  • Monchi M, Bellenfant F, Cariou A et al. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am. J. Respir. Crit. Care Med.158, 1076–1081 (1998).
  • ARDS Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N. Engl. J. Med.342, 1301–1308 (2000).
  • Amato MB, Barbas CS, Medeiros DM et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N. Engl. J. Med.338, 347–354 (1998).
  • Meade MO, Cook DJ, Guyatt GH et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA299, 637–645 (2008).
  • Diaz JV, Brower R, Calfee CS et al. Therapeutic strategies for severe acute lung injury. Crit. Care Med.38, 1644–1650 (2010).
  • Matthay MA, Zimmerman GA, Esmon C et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am. J. Respir. Crit. Care Med.167, 1027–1035 (2003).
  • Menezes SL, Bozza PT, Faria Neto HC et al. Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. J. Appl. Physiol.98, 1777–1783 (2005).
  • Gattinoni L, Pelosi P, Suter PM et al. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes? Am. J. Respir. Crit. Care Med.158, 3–11 (1998).
  • Suntharalingam G, Regan K, Keogh BF et al. Influence of direct and indirect etiology on acute outcome and 6-month functional recovery in acute respiratory distress syndrome. Crit. Care Med.29, 562–566 (2001).
  • Rocco PR, Zin WA. Pulmonary and extrapulmonary acute respiratory distress syndrome: are they different? Curr. Opin. Crit. Care11, 10–17 (2005).
  • Pelosi P, D’Onofrio D, Chiumello D et al. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur. Respir. J. Suppl.42, 48s–56s (2003).
  • Pittet JF, Mackersie RC, Martin TR et al. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am. J. Respir. Crit. Care Med.155, 1187–1205 (1997).
  • Ware LB, Matthay MA. The acute respiratory distress syndrome. N. Engl. J. Med.342, 1334–1349 (2000).
  • Pratt PC, Vollmer RT, Shelburne JD et al. Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy. Am. J. Pathol.95, 191–214 (1979).
  • Bachofen M, Weibel ER. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin. Chest Med.3, 35–56 (1982).
  • Bachofen M, Weibel ER. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am. Rev. Respir. Dis.116, 589–615 (1977).
  • Yang KY, Arcaroli JJ, Abraham E. Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am. J. Respir. Crit. Care Med.167, 1567–1574 (2003).
  • Warshawski FJ, Sibbald WJ, Driedger AA et al. Abnormal neutrophil–pulmonary interaction in the adult respiratory distress syndrome. Qualitative and quantitative assessment of pulmonary neutrophil kinetics in humans with in vivo111indium neutrophil scintigraphy. Am. Rev. Respir. Dis.133, 797–804 (1986).
  • Rinaldo JE, Borovetz H. Deterioration of oxygenation and abnormal lung microvascular permeability during resolution of leukopenia in patients with diffuse lung injury. Am. Rev. Respir. Dis.131, 579–583 (1985).
  • Azoulay E, Darmon M, Delclaux C et al. Deterioration of previous acute lung injury during neutropenia recovery. Crit. Care Med.30, 781–786 (2002).
  • Steinberg KP, Milberg JA, Martin TR et al. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med.150, 113–122 (1994).
  • Doerschuk CM. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation8, 71–88 (2001).
  • Lawrence MB, Springer TA. Neutrophils roll on E-selectin. J. Immunol.151, 6338–6346 (1993).
  • Williams MA, Solomkin JS. Integrin-mediated signaling in human neutrophil functioning. J. Leukoc. Biol.65, 725–736 (1999).
  • Newman PJ. The biology of PECAM-1. J. Clin. Invest.100, S25–S29 (1997).
  • Maekawa K, Futami S, Nishida M et al. Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD11b. J. Trauma44, 460–468 (1998).
  • Seekamp A, van Griensven M, Hildebrandt F et al. The effect of trauma on neutrophil L-selectin expression and sL-selectin serum levels. Shock15, 254–260 (2001).
  • Shijo H, Iwabuchi K, Hosoda S et al. Evaluation of neutrophil functions after experimental abdominal surgical trauma. Inflamm. Res.47, 67–74 (1998).
  • Doerschuk CM, Tasaka S, Wang Q. CD11/CD18-dependent and -independent neutrophil emigration in the lungs: how do neutrophils know which route to take? Am. J. Respir. Cell Mol. Biol.23, 133–136 (2000).
  • Skoutelis AT, Kaleridis V, Athanassiou GM et al. Neutrophil deformability in patients with sepsis, septic shock, and adult respiratory distress syndrome. Crit. Care Med.28, 2355–2359 (2000).
  • Suzuki T, Moraes TJ, Vachon E et al. Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am. J. Respir. Cell Mol. Biol.33, 231–247 (2005).
  • Donnelly SC, MacGregor I, Zamani A et al. Plasma elastase levels and the development of the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med.151, 1428–1433 (1995).
  • Gando S, Kameue T, Nanzaki S et al. Increased neutrophil elastase, persistent intravascular coagulation, and decreased fibrinolytic activity in patients with posttraumatic acute respiratory distress syndrome. J. Trauma42, 1068–1072 (1997).
  • Kodama T, Yukioka H, Kato T et al. Neutrophil elastase as a predicting factor for development of acute lung injury. Intern. Med.46, 699–704 (2007).
  • Endo S, Sato N, Yaegashi Y et al. Sivelestat sodium hydrate improves septic acute lung injury by reducing alveolar dysfunction. Res. Commun. Mol. Pathol. Pharmacol.119, 53–65 (2006).
  • Hayakawa M, Katabami K, Wada T et al. Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients. Shock33, 14–18 (2010).
  • Zeiher BG, Artigas A, Vincent JL et al. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit. Care Med.32, 1695–1702 (2004).
  • Tkalcevic J, Novelli M, Phylactides M et al. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity12, 201–210 (2000).
  • Carney DE, Lutz CJ, Picone AL et al. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation100, 400–406 (1999).
  • Ricou B, Nicod L, Lacraz S et al. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med.154, 346–352 (1996).
  • Christner P, Fein A, Goldberg S et al. Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis.131, 690–695 (1985).
  • Ayala A, Chung CS, Lomas JL et al. Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am. J. Pathol.161, 2283–2294 (2002).
  • Lomas-Neira J, Chung CS, Perl M et al. Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge. Am. J. Physiol. Lung Cell Mol. Physiol.290, L51–L58 (2006).
  • Stephens KE, Ishizaka A, Wu ZH et al. Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs. Am. Rev. Respir. Dis.138, 1300–1307 (1988).
  • Inoue S, Nakao A, Kishimoto W et al. Anti-neutrophil antibody attenuates the severity of acute lung injury in rats with experimental acute pancreatitis. Arch. Surg.130, 93–98 (1995).
  • Clark SC, Rao JN, Flecknell PA et al. Pentoxifylline is as effective as leukocyte depletion for modulating pulmonary reperfusion injury. J. Thorac. Cardiovasc. Surg.126, 2052–2057 (2003).
  • Looney MR, Su X, Van Ziffle JA et al. Neutrophils and their Fc γ receptors are essential in a mouse model of transfusion-related acute lung injury. J. Clin. Invest.116, 1615–1623 (2006).
  • Heflin JAC, Brigham KL. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J. Clin. Invest.68, 1253–1260 (1981).
  • Till GO, Johnson KJ, Kunkel R et al. Intravascular activation of complement and acute lung injury. J. Clin. Invest.69, 1126–1135 (1982).
  • Abraham E, Carmody A, Shenkar R et al. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol.279, L1137–L1145 (2000).
  • Lomas-Neira JL, Chung CS, Grutkoski PS et al. CXCR2 inhibition suppresses hemorrhage-induced priming for acute lung injury in mice. J. Leukoc. Biol.76, 58–64 (2004).
  • Lomas JL, Chung CS, Grutkoski PS et al. Differential effects of macrophage inflammatory chemokine-2 and keratinocyte-derived chemokine on hemorrhage-induced neutrophil priming for lung inflammation: assessment by adoptive cells transfer in mice. Shock19, 358–365 (2003).
  • Dunican AL, Leuenroth SJ, Grutkoski P et al. TNFα-induced suppression of PMN apoptosis is mediated through interleukin-8 production. Shock14, 284–288 (2000).
  • Dunican AL, Leuenroth SJ, Ayala A et al. CXC chemokine suppression of polymorphonuclear leukocytes apoptosis and preservation of function is oxidative stress independent. Shock13, 244–250 (2000).
  • Jimenez MF, Watson RW, Parodo J et al. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch. Surg.132, 1263–1269 (1997).
  • Ertel W, Keel M, Buergi U et al. Granulocyte colony-stimulating factor inhibits neutrophil apoptosis at the local site after severe head and thoracic injury. J. Trauma46, 784–792 (1999).
  • Goodman ER, Stricker P, Velavicius M et al. Role of granulocyte-macrophage colony-stimulating factor and its receptor in the genesis of acute respiratory distress syndrome through an effect on neutrophil apoptosis. Arch. Surg.134, 1049–1054 (1999).
  • Fialkow L, Fochesatto FL, Bozzetti MC et al. Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome. Crit. Care10, R155 (2006).
  • Kotecha S, Mildner RJ, Prince LR et al. The role of neutrophil apoptosis in the resolution of acute lung injury in newborn infants. Thorax58, 961–967 (2003).
  • Matute-Bello G, Liles WC, Radella F et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med.156, 1969–1977 (1997).
  • Abraham E. Neutrophils and acute lung injury. Crit. Care Med.31, S195–S199 (2003).
  • Martin TR. Neutrophils and lung injury: getting it right. J. Clin. Invest.110, 1603–1605 (2002).
  • Nelson S, Belknap SM, Carlson RW et al. A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group. J. Infect. Dis.178, 1075–1080 (1998).
  • Lagasse E, Weissman IL. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med.179, 1047–1052 (1994).
  • Perl M, Chung CS, Perl U et al. Beneficial versus detrimental effects of neutrophils are determined by the nature of the insult. J. Am. Coll. Surg.204, 840–852 (2007).
  • Teder P, Vandivier RW, Jiang D et al. Resolution of lung inflammation by CD44. Science296, 155–158 (2002).
  • Laufe MD, Simon RH, Flint A et al. Adult respiratory distress syndrome in neutropenic patients. Am. J. Med.80, 1022–1026 (1986).
  • Vansteenkiste JF, Boogaerts MA. Adult respiratory distress syndrome in neutropenic leukemia patients. Blut.58, 287–290 (1989).
  • Ognibene FP, Martin SE, Parker MM et al. Adult respiratory distress syndrome in patients with severe neutropenia. N. Engl. J. Med.315, 547–551 (1986).
  • Wunderink R, Leeper K Jr, Schein R et al. Filgrastim in patients with pneumonia and severe sepsis or septic shock. Chest119, 523–529 (2001).
  • Wiener-Kronish JP, Albertine KH, Matthay MA. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J. Clin. Invest.88, 864–875 (1991).
  • Walker DC, Behzad AR, Chu F. Neutrophil migration through preexisting holes in the basal laminae of alveolar capillaries and epithelium during streptococcal pneumonia. Microvasc. Res.50, 397–416 (1995).
  • Modelska K, Pittet JF, Folkesson HG et al. Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits. Am. J. Respir. Crit. Care Med.160, 1450–1456 (1999).
  • Sznajder JI. Strategies to increase alveolar epithelial fluid removal in the injured lung. Am. J. Respir. Crit. Care Med.160, 1441–1442 (1999).
  • Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med.163, 1376–1383 (2001).
  • Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am. Rev. Respir. Dis.142, 1250–1257 (1990).
  • Baker CS, Evans TW, Randle BJ et al. Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet353, 1232–1237 (1999).
  • Bardales RH, Xie SS, Schaefer RF et al. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am. J. Pathol.149, 845–852 (1996).
  • Guinee D Jr, Brambilla E, Fleming M et al. The potential role of BAX and BCL-2 expression in diffuse alveolar damage. Am. J. Pathol.151, 999–1007 (1997).
  • Nakamura M, Matute-Bello G, Liles WC et al. Differential response of human lung epithelial cells to Fas-induced apoptosis. Am. J. Pathol.164, 1949–1958 (2004).
  • Albertine KH, Soulier MF, Wang Z et al. Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Pathol.161, 1783–1796 (2002).
  • Lee KS, Choi YH, Kim YS et al. Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis. Respir. Med.102(3), 464–469 (2008).
  • Matute-Bello G, Liles WC, Steinberg KP et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J. Immunol.163, 2217–2225 (1999).
  • Hashimoto S, Kobayashi A, Kooguchi K et al. Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med.161, 237–243 (2000).
  • Kiener PA, Davis PM, Rankin BM et al. Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J. Immunol.159, 1594–1598 (1997).
  • Serrao KL, Fortenberry JD, Owens ML et al. Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am. J. Physiol. Lung Cell Mol. Physiol.280, L298–L305 (2001).
  • Powell WC, Fingleton B, Wilson CL et al. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr. Biol.9, 1441–1447 (1999).
  • Matsuno H, Yudoh K, Watanabe Y et al. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand. J. Rheumatol.28, 22–28 (2001).
  • Perl M, Chung CS, Perl U et al. Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury. Crit. Care Med.38, 1179–1186 (2010).
  • Perl M, Chung CS, Perl U et al. Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am. J. Respir. Crit. Care Med.176, 591–601 (2007).
  • Perl M, Chung CS, Lomas-Neira J et al. Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. Am. J. Pathol.167, 1545–1559 (2005).
  • Wortinger MA, Foley JW, Larocque P et al. Fas ligand-induced murine pulmonary inflammation is reduced by a stable decoy receptor 3 analogue. Immunology110, 225–233 (2003).
  • Matute-Bello G, Winn RK, Jonas M et al. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am. J. Pathol.158, 153–161 (2001).
  • Matute-Bello G, Frevert CW, Liles WC et al. Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria. Infect. Immun.69, 5768–5776 (2001).
  • Burns AR, Smith CW, Walker DC. Unique structural features that influence neutrophil emigration into the lung. Physiol. Rev.83, 309–336 (2003).
  • Predescu SA, Predescu DN, Malik AB. Molecular determinants of endothelial transcytosis and their role in endothelial permeability. Am. J. Physiol. Lung Cell Mol. Physiol.293, L823–L842 (2007).
  • Agre P. The aquaporin water channels. Proc. Am. Thorac. Soc.3, 5–13 (2006).
  • Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J. Biol. Chem.264, 20705–20713 (1989).
  • Sabharwal AK, Bajaj SP, Ameri A et al. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am. J. Respir. Crit. Care Med.151, 758–767 (1995).
  • Maniatis NA, Kotanidou A, Catravas JD et al. Endothelial pathomechanisms in acute lung injury. Vascul. Pharmacol.49, 119–133 (2008).
  • Moloney ED, Evans TW. Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome. Eur. Respir. J.21, 720–727 (2003).
  • Seki H, Tasaka S, Fukunaga K et al. Effect of Toll-like receptor 4 inhibitor on LPS-induced lung injury. Inflamm. Res.59, 837–845 (2010).
  • Fullerton DA, Eisenach JH, Friese RS et al. Impairment of endothelial-dependent pulmonary vasorelaxation after mesenteric ischemia/reperfusion. Surgery120, 879–884 (1996).
  • Rehm M, Bruegger D, Christ F et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation116, 1896–1906 (2007).
  • Atochina EN, Muzykantov VR, Al-Mehdi AB et al. Normoxic lung ischemia/reperfusion accelerates shedding of angiotensin converting enzyme from the pulmonary endothelium. Am. J. Respir. Crit. Care Med.156, 1114–1119 (1997).
  • Nowak K, Weih S, Metzger R et al. Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia–reperfusion injury of the lung in vivo. Am. J. Physiol. Lung Cell Mol. Physiol.293, L162–L169 (2007).
  • Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am. J. Respir. Crit. Care Med.172, 530–551 (2005).
  • de Heer HJ, Hammad H, Kool M et al. Dendritic cell subsets and immune regulation in the lung. Semin. Immunol.17, 295–303 (2005).
  • Holt PG, Stumbles PA. Regulation of immunologic homeostasis in peripheral tissues by dendritic cells: the respiratory tract as a paradigm. J. Allergy Clin. Immunol.105, 421–429 (2000).
  • van Rijt LS, Jung S, Kleinjan A et al.In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J. Exp. Med.201, 981–991 (2005).
  • Novak N, Bieber T. 2. Dendritic cells as regulators of immunity and tolerance. J. Allergy Clin. Immunol.121, S370–S374 (2008).
  • Morris PE, Glass J, Cross R et al. Role of T-lymphocytes in the resolution of endotoxin-induced lung injury. Inflammation21, 269–278 (1997).
  • Nakajima T, Suarez CJ, Lin KW et al. T cell pathways involving CTLA4 contribute to a model of acute lung injury. J. Immunol.184, 5835–5841 (2010).
  • Venet F, Chung CS, Huang X et al. Lymphocytes in the development of lung inflammation: a role for regulatory CD4+ T cells in indirect pulmonary lung injury. J. Immunol.183, 3472–3480 (2009).
  • D’Alessio FR, Tsushima K, Aggarwal NR et al. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J. Clin. Invest.119, 2898–2913 (2009).
  • Aggarwal NR, D’Alessio FR, Tsushima K et al. Regulatory T cell-mediated resolution of lung injury: identification of potential target genes via expression profiling. Physiol Genomics DOI: 10.1152/physiolgenomics.00131.2009 (2009) (Epub ahead of print).
  • Venet F, Huang X, Chung CS et al. Plasmacytoid dendritic cells control lung inflammation and monocyte recruitment in indirect acute lung injury in mice. Am. J. Pathol.176, 764–773 (2010).
  • Tsushima K, King LS, Aggarwal NR et al. Acute lung injury review. Intern. Med.48, 621–630 (2009).
  • Pene F, Zuber B, Courtine E et al. Dendritic cells modulate lung response to Pseudomonas aeruginosa in a murine model of sepsis-induced immune dysfunction. J. Immunol.181, 8513–8520 (2008).
  • Benjamim CF, Lundy SK, Lukacs NW et al. Reversal of long-term sepsis-induced immunosuppression by dendritic cells. Blood105, 3588–3595 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.